Melanoma remains one of the deadliest cutaneous malignancies worldwide, and despite advances in systemic therapy, recurrence and treatment resistance remain frequent challenges. Following the success of COVID-19 mRNA vaccines, mRNA-based cancer vaccines targeting melanoma antigens have emerged as a promising therapeutic direction. This review summarizes current evidence on mRNA melanoma vaccines, focusing on two leading delivery platforms: lipid nanoparticles (LNPs) and dendritic cell (DC) vaccines. A comprehensive search of MEDLINE, Embase, and Scopus from 2015 to 2025 identified clinical trials, preclinical studies, and review articles evaluating mRNA vaccine constructs and delivery strategies. Completed clinical studies demonstrate that personalized LNP-formulated mRNA vaccines can enhance neoantigen-specific T-cell responses and improve recurrence-free survival, particularly when combined with immune checkpoint inhibitors. DC-based mRNA vaccines also show potent immunogenicity, with stronger responses observed when DC maturation is optimized. Ongoing trials continue to investigate next-generation LNP formulations, DC priming strategies, and personalized neoantigen approaches. Overall, current evidence indicates that both LNP and DC platforms can augment antitumor immunity by broadening T-cell responses and enhancing checkpoint inhibition. Continued refinement of delivery vehicles, neoantigen selection, and scalable manufacturing processes will be essential to realizing the full clinical potential of mRNA vaccines in melanoma.
10 June 2025 in Children and Youth Services Review
One of the world’s most densely populated cities in the World, Dhaka continues to grapple with its persisting challenge of child malnutrition. While food shortages, food insecurity, and inadequate feeding practices contribute to child malnutrition, various social and economic determinants, including maternal education, family household income, and geographic residence further exacerbate the problem. While existing interventions like the Health Sector Support Project and National Nutrition Programme have made strides in reducing short-term and long-term child malnutrition, challenges such as insufficient coverage hamper its overall scope and effectiveness. In order to address issues hampering funding capacity and the breadth and quality of nutrition-related services, it is necessary to understand the factors affecting them, including political commitment toward child nutrition, policy alignment, program design and implementation, monitoring and evaluation, and intervention strategies and service delivery. Moving forward, comprehensive strategies taking into account political prioritization, multisectoral coordination, and targeted primary intervention strategies are crucial for tackling child malnutrition effectively in LMICs and cities like Dhaka and beyond.